文献速递中医儿科中药与中成药合理使用

东亚传统医学治疗儿童特发性矮小的比较效果:系统综述与网络Meta分析

Comparative effectiveness of East Asian traditional medicine for treatment of idiopathic short stature in children: Systematic review and network meta-analysis.
PubMed 文献 · Integr Med Res · 2022-01-05

本研究通过系统综述与网络Meta分析比较多种东亚传统医学(EATM)疗法治疗儿童特发性矮小(ISS)的效果。共纳入14项随机对照试验、1066名参与者,主要结局为生长速度(GV)。结果显示中药(HM)联合生长激素(GH)在提高年GV方面可能优于其他EATM疗法及单用GH,但需更多长期高质量试验证实。

要点

  • 中药联合生长激素可能提高ISS患儿年生长速度。
  • 中药联合生长激素效果可能优于针灸、单用中药等疗法。
  • 与单用生长激素相比未见显著差异,需长期验证。

核心结论

  • 对于ISS患儿,中药联合生长激素可能具有较大获益,可能优于其他EATM疗法及单用生长激素。

研究设计与样本

  • 系统综述与网络Meta分析,检索14个电子数据库,纳入14项随机对照试验,共1066名参与者。

主要发现

  • 中药联合生长激素在提高年生长速度上显著优于针灸(WMD 3.20 cm,95%CI 0.40至5.99)和单用中药(WMD 3.70 cm,95%CI 1.41至5.99)。
  • 中药联合生长激素与单用生长激素相比无显著差异(WMD 1.18 cm,95%CI -0.27至2.63)。
  • SUCRA排序显示中药联合生长激素提高生长速度最有效,其次为生长激素、中药联合穴位按压和单用中药。
  • 未报告严重不良事件。

关键数值与推荐

  • 主要结局为生长速度(GV),采用SUCRA排序和GRADE方法评估证据质量。

临床怎么用

  • 临床可考虑中药联合生长激素作为ISS患儿的治疗选择,但需结合长期高质量试验证据。

局限性

  • 需要更多长期、高质量的试验来确认研究结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Idiopathic short stature (ISS) is a common problem in children and causes many economic and social burdens. In Asian countries, East Asian traditional medicine (EATM) therapies are widely used for children with ISS. In this study, we compared and ranked various EATM therapies for the treatment of pediatric ISS using network meta-analysis. METHODS: Randomized controlled trials that evaluated various EATMs for pediatric ISS were found through searching 14 electronic databases. The primary outcome was growth velocity (GV). The comparative effectiveness of the treatments was ranked based on the surface under the cumulative ranking curve (SUCRA) and the risk of bias was assessed. The quality of evidence was assessed using the Grading of Recommendations, Assessment, Development, and Evaluations approach. RESULTS: Fourteen studies comprising 1,066 participants were included. HM plus GH showed statistically significant superiority over other EATM therapies including acupuncture (weighted mean difference (WMD) 3.20 cm, 95% confidence interval (CI) 0.40 to 5.99) and HM (WMD 3.70 cm, 95% CI 1.41 to 5.99) for improving GV per year, although there was no difference compared with GH alone (WMD 1.18 cm, 95% CI -0.27 to 2.63). SUCRA indicated that HM plus GH was the most effective therapy for increasing GV, followed by GH, HM plus acupressure, and HM. No serious adverse events were reported. CONCLUSION: For the treatment of ISS, HM plus GH might have a large beneficial effect and might be a better option than EATM therapies and GH alone. However, more long-term, high-quality trials are warranted to confirm the findings. PROTOCOL REGISTRATION: PROSPERO (https://www.crd.york.ac.uk/prospero/), CRD42020187160.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Lee B, Kwon CY, Jang S, et al. Comparative effectiveness of East Asian traditional medicine for treatment of idiopathic short stature in children: Systematic review and network meta-analysis. Integr Med Res. 2022. PMID: 35145854. doi:10.1016/j.imr.2022.100832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。